ABSTRACT: Background. Metastasis in a tracheostomy site occurs rarely, usually from head and neck primary tumors. Breast cancer relapse to a tracheostomy has not been described to date. Methods and Results. A 71-year-old women presented with symptoms typical of central airway obstruction, 10 years after mastectomy for breast cancer. Fifteen months before admission, when cancer followup was negative, she also had surgery for cerebral aneurysm and a tracheostomy. On admission, CT showed a solid mass infiltrating the tracheostomy tract and projecting into the airway. Tracheal obstruction palliation was achieved by laser resection of the endotracheal growth and stenting. Histology documented breast cancer metastasis. Conclusions. Tracheostomy site metastasis was the presenting sign of late-onset relapse of breast cancer. This case supports the concept of surgery-driven interruption of micrometastatic cancer dormancy, in that the initial recurrence developed in a tracheostomy that was surgically created several years after resection of the primary tumor.
INTRODUCTION
Relapse of head and neck cancer at a tracheostomy site is unusual but well documented. [1] [2] [3] The mechanisms that have been proposed to explain such recurrence include intraoperative implantation from tumor-contaminated instruments, and growth at the stoma site of cancer cells disseminated by the lymphatic or hematogenous route. Moreover, it has been postulated that local inflammation and tissue trauma around the stoma may provide a favorable microenvironment for the growth of dormant metastases. 4 Patients with breast cancer, the most frequent malignant tumor among females, are at risk of developing metastases ubiquitously during their entire lifetime. 5 To our knowledge, however, metastasis of cancer of the breast to a tracheostomy has not been described previously.
CASE REPORT
A 71-year-old woman was admitted to our hospital as an emergency for acute respiratory failure on January 6, 2010. The patient reported nonproductive cough for several weeks, hemoptysis and progressive dyspnea in the previous days. She had signs of central airway obstruction with tirage and cyanosis, and her peripheral blood O 2 saturation was 86% in room air. Inspection of her neck revealed a tracheostomy scar with reddened skin, under which a 3-cm solid mass extending deeply in the neck was palpable. The patient had a history of cancer of the right breast, diagnosed in 2000. This lesion was invasive ductal carcinoma positive for progesterone and estrogen receptors and negative for human epidermal growth factor receptor 2. The tumor was 25 mm in diameter, stage pT2, pN1b, G2. The serum level of CA 15-3 was 38.6 U/mL (normal range, 0-30 U/mL). Treatment was effected with radical mastectomy, followed by chemotherapy (6 cycles of cyclophosphamide, methotrexate, and fluorouracil), radiotherapy (50 Gy), and 5-year tamoxifen. Semiannual follow-up was then carried out regularly, with negative findings. In September 2008 the patient developed a ruptured cerebral aneurysm that required surgical clipping and cerebral decompression. She also needed a tracheostomy that was made without encountering any tissue abnormalities in the neck. Recovery after the neurosurgical procedure was satisfactory, with minor neurologic deficit, and the tracheostomy cannula was removed after 8 months, followed by spontaneous closure of the stoma. The patient was subsequently lost to follow-up.
On admission, approximately 15 months after the cerebrovascular accident, staging with showed a 3-Â 4-cm solid growth in the soft tissues of the neck above the sternal notch that infiltrated the tracheotomy tract. This growth projected into the tracheal lumen 3 cm below the vocal cords, severely obstructing the airway (5 mm free space) ( Figures 1A-C) . Moreover, CT demonstrated a single 1.8-cm nodule in the right upper lung lobe, suspicious for malignancy ( Figure 2 ). There was no other evidence of metastases elsewhere. Tracheo-bronchoscopy confirmed approximately 90% obstruction of the airway, caused by a 2.5-cm solid mass growing from the second and third tracheal rings into the lumen ( Figure 3A ). The bulk of the endotracheal growth was removed with diode laser through the rigid bronchoscope, and clearance of the airway was obtained ( Figure 3B ). Histology of the excised endotracheal growth revealed invasive ductal carcinoma of the breast with positivity for progesterone and estrogen receptors ( Figures 4A and 4B) , with an immunohistochemical pattern mirroring that of the primary cancer resected 10 years earlier ( Figures 4B and 4C ). Needle biopsy of the right lung nodule also showed the same immunohistochemical features of breast cancer metastasis. The serum CA 15-3 level was normal (20.8 U/mL). After laser ablation of the endotracheal mass, a silicone 12-mm tracheal stent was positioned (Dumon; Novatech, La Ciotat, France). Therapy with aromatase inhibitor (Exemestane) was instituted, but the patient did not respond and died with disseminated metastases on June 26, 2010, approximately 6 months after diagnosis of breast cancer relapse.
DISCUSSION
Breast cancer metastases frequently localize in the lower respiratory tract, 6, 7 whereas tracheal involvement is uncommon and usually characterized by compression/ infiltration from adjacent pulmonary or paratracheal lymph node metastases. 8 Direct metastases of breast cancer to the trachea are exceedingly rare; a search of the literature revealed that only 3 such cases have been reported. 9, 10 The rarity of the case presented here may be explained by the scarce propensity of breast cancer to relapse at tracheal level, in addition to the fact that patients with exceptional cases of breast cancer need a tracheostomy. An increased level of CA 15-3 is often associated with metastatic breast carcinoma, 11 but in our patient the serum level of this marker was normal when recurrence was diagnosed. Evidence of endotracheal metastasis of breast cancer at the tracheostomy was the first indication of relapsed disease, 10 years after resection of the primary tumor. Notably, the latter was estrogen receptor-positive, a feature associated with greater hazard of recurrence from years 5 to 12.
12 Breast cancer relapse more than 10 years after apparently radical resection of the primary lesion is a well-documented event.
13,14 A possible mechanism for late recurrence of breast cancer is the reactivation of fully malignant tumor cells seeded before or at the time of primary tumor resection that remained "dormant" for many years. 4, 15 In addition, it has been shown that wounds are a favorable microenvironment for tumor growth and that local tissue trauma and inflammation contribute to tumorigenesis and malignant disease progression. 4, 15, 16 It is noteworthy that in our patient the tracheostomy was made without encountering any abnormalities in the anterior neck tissues, thus ruling out a preexisting clinically detectable relapse. Therefore, we hypothesize that the surgical procedures performed in September 2008 (clipping of aneurysm and tracheostomy) facilitated the outgrowth of otherwise dormant circulating cancer cells at the tracheostomy, a site characterized by inflammation and granulation caused by the tracheal cannula. Fifteen months elapsed from tracheostomy placement and symptomatic diagnosis of the 3-Â 4-cm recurrent growth at the stoma site, a time interval that may seem exceedingly short for such a large recurrence to develop. However, in agreement with the short volume doubling time of breast cancer recurrences, reported to range between 25 and 51 days, 17, 18 we estimated that a micrometastasis growing up to 4 cm in diameter in 15 months would have a volume doubling time of about 30 days. Interestingly, a review of percutaneous endoscopic gastrostomy (PEG)-associated metastases from head and neck tumors reported that stomal recurrence became clinically evident at a mean of 8 months (range, 2-24 months) after PEG placement. 19 In our patient, persistent cough was long misinterpreted as chronic bronchitis, and the diagnosis of tracheal metastasis was delayed until the occurrence of acute respiratory failure with tirage, when the airway lumen was nearly occluded. When the disease is multimetastatic, as in our case, treatment is symptom palliation, associated with chemotherapy and hormone therapy, if feasible. 10, 20 Laser resection of endotracheal metastasis and stent placement are recommended to obtain tracheal canalization when acute respiratory failure occurs. These endoscopic procedures may improve the quality of life and prolong survival for a brief period. Regardless of the primary tumor histology and the type of treatment, however, the presence of tracheal metastasis from distant malignancies points to widespread disease and dismal prognosis, with survival ranging from a few months to 2 years. 10, 20, 21 One of the 3 published cases of breast cancer recurrence to the trachea survived 8 months, and no information is available on the survival period of the other 2.
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CONCLUSIONS
Late-onset metastasis of breast cancer is often associated with disseminated disease. In the case presented, tracheal obstruction was the initial sign of late recurrence in a tracheostomy, a distant site of breast cancer relapse that has not been described to date. Moreover, this case supports the concept of surgery-driven interruption of circulating breast cancer cell dormancy, given that the initial and largest recurrence developed in a tracheostomy that was surgically created 8.5 years after removal of the primary tumor.
